Related Experiment Video
Updated: May 10, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Acute stroke management in patients with known or suspected atrial fibrillation
Jennifer L Mandzia1, Michael D Hill
1Calgary Stroke Program, Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, 1403 29th St NW, Calgary, Alberta, Canada.
Insights
Atrial fibrillation (AF) increases stroke risk, particularly in older adults. New oral anticoagulants offer benefits but require specific management strategies for stroke patients.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Background:
- Atrial fibrillation (AF) is a significant cause of ischemic stroke, leading to severe outcomes, especially in the elderly.
- AF-related strokes are frequently large and associated with high mortality rates.
- Newer oral anticoagulants present advantages over warfarin but introduce complex management challenges.
Purpose of the Study:
- To review and discuss the management of anticoagulation in patients with acute ischemic stroke and atrial fibrillation.
- To address the unique aspects of anticoagulation management during the hyperacute and acute phases of stroke.
- To provide guidance on managing intracranial hemorrhage in anticoagulated patients.
Main Methods:
- Review of current literature and clinical guidelines regarding anticoagulation in AF patients experiencing stroke.
- Discussion of treatment options for acute ischemic stroke in anticoagulated individuals.
- Analysis of anticoagulation discontinuation and initiation timing with various oral anticoagulants.
Main Results:
- Acute stroke management is not altered by AF, but anticoagulation management requires specific protocols.
- New oral anticoagulants offer improved safety and dosing profiles compared to warfarin.
- Strategies for managing intracranial hemorrhage in anticoagulated patients are crucial.
Conclusions:
- Optimal management of anticoagulation is essential for AF patients experiencing ischemic stroke.
- Understanding the nuances of old and new oral anticoagulants is critical for effective patient care.
- Further investigation into cardioembolic stroke workup in AF patients is warranted.
Abstract:
Atrial fibrillation (AF) is an important cause of ischemic stroke, especially in older individuals. Strokes attributed to AF are often large and result in a high rate of fatality. The new oral anticoagulants offer advantages over warfarin in terms of dosing, pharmacokinetic characteristics, and lower rates of intracranial hemorrhage, but pose new management questions for physicians treating these patients. The management of acute stroke is not modified by the presence of AF, but is unique with respect to management of anticoagulation in the hyperacute and acute phases. We will review and discuss acute treatment options in anticoagulated patients with ischemic stroke, anticoagulation discontinuation, and timing of initiation with old and new oral anticoagulants, and managing intracranial hemorrhage in anticoagulated patients. We will end by briefly discussing investigations of stroke patients with suspected cardioembolic stroke.
Related Concept Videos
Atherosclerosis IV: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
Dysrhythmias VI: Management of Dysrhythmias
Venous Thrombosis III: Interprofessional Care
Cardiopulmonary Resuscitation IV: Pharmacological Management
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

